Study of AR-67 (DB-67) in Myelodysplastic Syndrome (MDS)
type: MedicalStudy
description: Phase 2 Study of AR-67 (DB-67) in Myelodysplastic Syndrome(MDS)
status: UNKNOWN
study design: INTERVENTIONAL
phase: PHASE2
start date: 2009-06
end date: 2014-12
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00956787
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Arno Therapeutics
study subject: Myelodysplastic Syndrome
keywords: PHASE2
keywords: INTERVENTIONAL
keywords: UNKNOWN
keywords: Myelodysplastic Syndrome

AI Analytics
type: Organization